|
🐜
|
Catastrophic Antiphospholipid Syndrome: Clues to the Pathogenesis from a Series of 80 Patients
21 auth.
R. Asherson,
R. Cervera,
J. Piette,
Y. Shoenfeld,
G. Espinosa,
M. Petri,
Eugene Lim,
T. Lau,
A. Gurjal,
A. Jędryka-Góral,
...
H. Chwalińska-Sadowska,
R. Dibner,
J. Rojas-Rodríguez,
M. García-Carrasco,
J. T. Grandone,
A. Parke,
P. Barbosa,
C. Vasconcelos,
M. Ramos-Casals,
J. Font,
M. Ingelmo
|
8 |
2001 |
8
🐜
|
|
🐜
|
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
32 auth.
R. Cervera,
M. Khamashta,
Y. Shoenfeld,
M. Camps,
S. Jacobsen,
E. Kiss,
M. Zeher,
A. Tincani,
I. Kontopoulou-Griva,
M. Galeazzi,
F. Bellisai,
P. Meroni,
R. Derksen,
D. Groot,
E. Gromnica-ihle,
...
M. Baleva,
M. Mosca,
S. Bombardieri,
F. Houssiau,
J. Gris,
I. Quéré,
E. Hachulla,
C. Vasconcelos,
B. Roch,
A. Fernández-Nebro,
J. Piette,
G. Espinosa,
S. Bucciarelli,
C. Pisoni,
M. Bertolaccini,
M. Boffa,
G. Hughes
|
8 |
2008 |
8
🐜
|
|
🐜
|
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
8 auth.
S. Bucciarelli,
G. Espinosa,
R. Cervera,
D. Erkan,
J. Gómez-Puerta,
M. Ramos-Casals,
...
J. Font,
R. Asherson
|
8 |
2006 |
8
🐜
|
|
🐜
|
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry.
7 auth.
I. Rodríguez-Pintó,
Marta Moitinho,
I. Santacreu,
Y. Shoenfeld,
D. Erkan,
G. Espinosa,
...
R. Cervera
|
7 |
2016 |
7
🐜
|
|
🐢
|
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
8 auth.
H. Berman,
I. Rodríguez-Pintó,
R. Cervera,
N. Morel,
N. Costedoat-Chalumeau,
D. Erkan,
...
Y. Shoenfeld,
G. Espinosa
|
7 |
2013 |
7
🐢
|
|
🦁
|
Adrenal Involvement in the Antiphospholipid Syndrome: Clinical and Immunologic Characteristics of 86 Patients
10 auth.
G. Espinosa,
E. Santos,
R. Cervera,
J. Piette,
G. de la Red,
V. Gil,
...
J. Font,
R. Couch,
M. Ingelmo,
R. Asherson
|
7 |
2003 |
7
🦁
|
|
🐜
|
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients
11 auth.
R. Cervera,
R. Asherson,
M. Acevedo,
J. Gómez-Puerta,
G. Espinosa,
G. D. L. Red,
...
V. Gil,
M. Ramos-Casals,
M. García-Carrasco,
M. Ingelmo,
J. Font
|
7 |
2004 |
7
🐜
|
|
🐢
|
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
13 auth.
R. Cervera,
I. Rodríguez-Pintó,
S. Colafrancesco,
F. Conti,
G. Valesini,
Cristina Rosário,
N. Agmon-Levin,
Y. Shoenfeld,
Cláudia Ferrão,
R. Faria,
...
C. Vasconcelos,
F. Signorelli,
G. Espinosa
|
7 |
2014 |
7
🐢
|
|
🦁
|
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
10 auth.
G. Espinosa,
J. Font,
D. Tàssies,
A. Vidaller,
R. Deulofeu,
A. López-Soto,
...
R. Cervera,
A. Ordinas,
M. Ingelmo,
J. Reverter
|
7 |
2002 |
7
🦁
|
|
🐬
|
Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.
D. Erkan,
G. Espinosa,
R. Cervera
|
7 |
2010 |
7
🐬
|
|
🐬
|
Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review.
X. Bosch,
A. Guilabert,
G. Espinosa,
E. Mirapeix
|
7 |
2007 |
7
🐬
|
